Komori
KYORIN Pharmaceutical (4569) · InitiativeHead office relocation costs recorded

Resolution to Relocate the Head Office and Changes in Estimates for Relocation-Related Assets and Liabilities

First written in FY2024-Q1. . Latest entry: FY2025-H1.

4entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2024-Q1 – FY2025-H12023: 220232024: 22024
Same theme, other companies
Asset Retirement Obligations Associated with the Relocation of the Head Office and Related MattersA theme 11 companies write about · 8 as a headwind · 2 as a tailwind

2 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1Head office relocation costs recordedAnnual report

    「Head office relocation costs」

    The Company recognized ¥64 million in costs related to the head-office relocation as an extraordinary loss for the current interim consolidated accounting period.
  2. FY2024-Q3¥474 million impact on profit from changes in estimatesAnnual report

    「In addition, estimates were revised after new information was obtained regarding restoration costs under the real estate lease agreement, and an asset retirement obligation of ¥623 million was recognized. As a result of this change in estimate, operating income, ordinary income and profit before income taxes for the cumulative third quarter of the current consolidated fiscal year each decreased by ¥474 million.」

    The asset retirement obligation recognized in connection with the head-office relocation amounted to ¥623 million, and the impact of the change in estimates on operating income and other profit measures for the cumulative period increased to a reduction of ¥474 million.
  3. FY2024-Q2¥328 million impact on profit from changes in estimatesAnnual report

    「Following the resolution to relocate the head office during the first quarter of the current consolidated fiscal year, the useful lives of fixed assets that are not expected to be used after the relocation were shortened and changed prospectively. In addition, estimates were revised after new information was obtained regarding restoration costs under the real estate lease agreement, and an asset retirement obligation of ¥650 million was recognized. As a result of this change in estimate, operating income, ordinary income and profit before income taxes for the cumulative second quarter of the current consolidated fiscal year each decreased by ¥328 million.」

    For the shortening of useful lives and recognition of the ¥650 million asset retirement obligation associated with the head-office relocation, the reduction in profit for the cumulative period increased from ¥164 million to ¥328 million.
  4. FY2024-Q1First statedAnnual report

    「Following the decision to relocate the head office during the first quarter of the consolidated fiscal year, we shortened and prospectively changed the useful lives of fixed assets that are not expected to be used after the relocation. In addition, based on new information regarding restoration costs under the real estate lease, we changed our estimate and recorded asset retirement obligations of ¥650 million. As a result of this change in estimate, operating profit, ordinary profit and profit before income taxes for the first six months of the consolidated fiscal year each decreased by ¥164 million.」

    The decision to relocate the head office led to shortened useful lives for fixed assets not expected to be used after the move and recognition of ¥650 million in asset retirement obligations. The change in estimate reduced operating profit and other profit measures by ¥164 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.